Make a Gift
College of Health Sciences
Healthcare Professionals
Volunteering
MyChart Login
Clinical Trials
Career Opportunities
Contact Us
≡
Medical Services
Find a Provider
Patients & Visitors
Classes & Events
Clinical Trials
Contact a Patient
Dining
Donate Blood
Parking
Patient Feedback
Pay Bills Online
Pricing Transparency
Visiting Hours
MyChart Login ›
Report Sexual Misconduct ›
Locations
News & Blog
News & Stories
Live Well Blog
Live Well Magazine
Webinars
Subscribe to Newsletter
Coronavirus FAQ
Events
About Us
About UCI Health
340B Program
Classes & Events
Community Health
Compliance
Contact Us
Giving
Human Resources
News
Nondiscrimination
Planning Administration
Pricing Transparency
Publications
Quality & Safety
Virtual Tour
Volunteering
Site Search
Site Search
Home
›
Clinical Trials
›
Cancer Clinical Trial
›
Pancreas
›
MM-398-07-02-03: A randomized, open-label phase 2 study of irinotecan liposomal injection (lip-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine in patients with previously untreated, metastatic pancreatic adenocarcinoma
Print
A
A
A
COVID-19 vaccine and protecting your health ›